View of A Severe Hyponatremia in a Renal Cell Carcinoma Patient Treated with Pembrolizumab: Possible Immune Checkpoint Inhibitor–Induced Secondary Adrenal Insufficiency

Return to Article Details A Severe Hyponatremia in a Renal Cell Carcinoma Patient Treated with Pembrolizumab: Possible Immune Checkpoint Inhibitor–Induced Secondary Adrenal Insufficiency Download Download PDF